Ro launches the GLP-1 Supply Tracker News provided by Ro May 29, 2024, 09:01 ET Tool gives patients real-time insights on GLP-1 drug shortages and automated, localized supply alerts NEW YORK, May 29, 2024 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today launched the GLP-1 Supply Tracker, an interactive tool to give patients real-time insights on GLP-1 drug shortages and automated, localized supply alerts
And without clinical data comparing salt forms to the base compound, nobody can say with certainty how these differences translate to real-world outcomes
If you suspect an adverse reaction to Wegovy, you can report it through the MHRA Yellow Card scheme
10.1056/NEJM199807233390404
Some people experience it with every dose escalation